FOXP2/FABP4 axis promotes bladder cancer aggressiveness by driving lipid metabolic reprogramming to activate FAK/Src signaling

Urologic Oncology: Seminars and Original Investigations · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles